Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000529127 | SCV000659201 | uncertain significance | Dilated cardiomyopathy 1KK | 2022-06-24 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1042 of the MYPN protein (p.Arg1042His). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 477756). This variant has not been reported in the literature in individuals affected with MYPN-related conditions. This variant is present in population databases (rs140439935, gnomAD 0.01%). |
Mayo Clinic Laboratories, |
RCV002261123 | SCV002541075 | uncertain significance | not provided | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002325105 | SCV002607364 | uncertain significance | Cardiovascular phenotype | 2022-03-09 | criteria provided, single submitter | clinical testing | The p.R1042H variant (also known as c.3125G>A), located in coding exon 14 of the MYPN gene, results from a G to A substitution at nucleotide position 3125. The arginine at codon 1042 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |